Hypertension
Overview
Hypertension, also referred to as high blood pressure, is a
condition in which the arteries have persistently elevated blood pressure. Many
factors can affect blood pressure, including hormone levels, water and salt
levels in body and condition of kidneys, nervous system, or blood vessels. Most
people with high blood pressure have no signs or symptoms, even if blood
pressure readings reach dangerously high levels. Although a few people with
early-stage high blood pressure may have dull headaches, dizzy spells or a few
more nosebleeds than normal, these signs and symptoms typically don't occur
until high blood pressure has reached a severe.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1418399-hypertension-pipeline-review-h1-2017
Hypertension Industry Major Outlook
The Pharmaceutical and Healthcare latest pipeline guide
Hypertension - Pipeline Review, H1 2017, provides comprehensive information on
the therapeutics under development for Hypertension (Cardiovascular), complete
with analysis by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete research
and development history and latest news and press releases.
The Hypertension (Cardiovascular) pipeline guide also reviews
of key players involved in therapeutic development for Hypertension and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules developed by
Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical,
Discovery and Unknown stages are 7, 35, 35, 31, 89, 9 and 1 respectively.
Similarly, the Universities portfolio in Preclinical and Discovery stages
comprises 24 and 11 molecules, respectively.
Hypertension (Cardiovascular) pipeline guide helps in
identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter
strategies to gain competitive advantage. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a
real time basis.
Hypertension - Competitive Analysis
Key players are making innovative
developments in Hypertension industry. The same will help in improving the market
performance. Heavy investments are made by major players in the R&D sector
Scope
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Hypertension (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Hypertension (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Hypertension (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Hypertension (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Hypertension (Cardiovascular)
- The pipeline guide reviews pipeline therapeutics for Hypertension (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Hypertension (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Hypertension (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Hypertension (Cardiovascular)
.Continued
For Detailed Reading Please visit @
https://www.wiseguyreports.com/reports/1418399-hypertension-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt.
Ltd. and offers premium progressive statistical surveying, market research
reports, analysis & forecast data for industries and governments around the
globe. Wise Guy Reports understand how essential statistical surveying
information is for your organization or association. Therefore, we have
associated with the top publishers and research firms all specialized in
specific domains, ensuring you will receive the most reliable and up to date
research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment